Clinical utility of far infrared therapy in hemodialysis patients

Clinical utility of far infrared therapy to improve access blood flow and pain control in hemodialysis patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CRIS

Registry ID

KCT0001623

Enrollment

Registered

2015-09-11

Start date

2013-06-24

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : FIR therapy was administered for 40 min during HD three times per week and continued for 12 months. Electrified ceramic plates were positioned approximately 25 cm above the skin surfa

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All enrolled patients are greater than 20 years old. They were maintained with 4 h of HD three times per week in our clinic.

Exclusion criteria

Exclusion criteria: We excluded patients who underwent HD treatment with catheter, who couldn't maintain at a frequency three times per week, or who couldn't explain and complain pain such as dementia,

Design outcomes

Primary

Measure	Time frame
access blood flow and patency,	—

Secondary

Measure	Time frame
needling pain	—

Countries

Korea, Republic of

Contacts

Public ContactSoo Jeong Choi

Soon Chun Hyang University Hospital Bucheon

Outcome results